KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adient (ADNT) Other Accumulated Expenses (2016 - 2025)

Adient (ADNT) has disclosed Other Accumulated Expenses for 10 consecutive years, with $731.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Accumulated Expenses rose 1.67% year-over-year to $731.0 million, compared with a TTM value of $731.0 million through Dec 2025, up 1.67%, and an annual FY2025 reading of $734.0 million, down 3.29% over the prior year.
  • Other Accumulated Expenses was $731.0 million for Q4 2025 at Adient, roughly flat from $734.0 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $883.0 million in Q4 2021 and bottomed at $589.0 million in Q1 2023.
  • Average Other Accumulated Expenses over 5 years is $682.4 million, with a median of $677.5 million recorded in 2021.
  • The sharpest move saw Other Accumulated Expenses increased 20.63% in 2021, then decreased 29.33% in 2022.
  • Year by year, Other Accumulated Expenses stood at $883.0 million in 2021, then fell by 29.33% to $624.0 million in 2022, then decreased by 4.01% to $599.0 million in 2023, then increased by 20.03% to $719.0 million in 2024, then increased by 1.67% to $731.0 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for ADNT at $731.0 million in Q4 2025, $734.0 million in Q3 2025, and $691.0 million in Q2 2025.